Evidence map›Paper›PMID 35174809›Full record

ArticleRetina (Philadelphia, Pa.)2022

MULTIMODAL ASSESSMENTS OF DRUSENOID PIGMENT EPITHELIAL DETACHMENTS IN THE AGE-RELATED EYE DISEASE STUDY 2 ANCILLARY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY STUDY COHORT.

Alisa T Thavikulwat, Tharindu De Silva, Elvira Agrón, Tiarnan D L Keenan, Cynthia A Toth, Emily Y Chew, Catherine A Cukras, Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group

Open access · greenAbstract read
In one paragraph

Article in Retina (Philadelphia, Pa.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Non neovascular Age - related macular degeneration - Review on clinical and imaging advances.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alisa T ThavikulwatNational Eye Institute, National Institutes of Health, Bethesda, Maryland; and.ORCID 0000-0001-6545-3156
Tharindu De SilvaNational Eye Institute, National Institutes of Health, Bethesda, Maryland; and.
Elvira AgrónNational Eye Institute, National Institutes of Health, Bethesda, Maryland; and.
Tiarnan D L KeenanNational Eye Institute, National Institutes of Health, Bethesda, Maryland; and.
Cynthia A TothDepartment of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
Emily Y ChewNational Eye Institute, National Institutes of Health, Bethesda, Maryland; and.
Catherine A CukrasNational Eye Institute, National Institutes of Health, Bethesda, Maryland; and.
Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group
National Institutes of Health · USDuke Medical Center · US

Funding

Age-Related Eye Disease Follow-up Study (AREDS) Follow-up StudyZIAEY000489 · NEI · NATIONAL EYE INSTITUTE · PI CHEW, EMILY Y · 2009 to 2025
$639k
Intramural NIH HHS Z99 EY999999
6 · The paper itself

Abstract

purposeTo identify features correlating with drusenoid pigment epithelial detachment (DPED) progression in the Age-Related Eye Disease Study 2 Ancillary spectral-domain optical coherence tomography study cohort.

methodsIn this retrospective analysis of a prospective longitudinal study, eyes with intermediate age-related macular degeneration and DPEDs were followed longitudinally with annual multimodal imaging.

resultsThirty-one eyes of 25 participants (mean age 72.6 years) in the Age-Related Eye Disease Study 2 Ancillary spectral-domain OCT substudy (A2A study) had DPED identified in color fundus images. Spectral-domain optical coherence tomography inspection confirmed a subretinal pigment epithelium drusenoid elevation of ≥433 µm diameter in 25 eyes (80.6%). Twenty-four of these eyes were followed longitudinally (median 4.0 years), during which 7 eyes (29.2%) underwent DPED collapse (with 3/7 further progressing to geographic atrophy), 6 (25.0%) developing neovascular age-related macular degeneration, and 11 (45.8%) maintaining DPED persistence without late age-related macular degeneration. On Kaplan-Meier analysis, mean time to DPED collapse was 3.9 years. Both DPED collapse and progression to neovascular age-related macular degeneration were preceded by the presence of hyperreflective foci over the DPED.

conclusionThe natural history of DPED comprises collapse (sometimes followed by the development of atrophy), vascularization followed by exudation, or DPED persistence. Spectral-domain optical coherence tomography can confirm retinal pigment epithelial elevation caused by drusenoid accumulation and facilitate the identification of high-risk features that correlate with progression.

Indexed as

Macular DegenerationRetinal DetachmentRetinal DrusenAgedHumansLongitudinal StudiesProspective StudiesRetinal Pigment EpitheliumRetrospective StudiesTomography, Optical CoherenceVisual Acuity

Identifiers

PMID35174809
PMCPMC11550875
OpenAlexW4212849361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.